Upfield Announces Strategic Partnership with Starling (Earthworm and Airbus) to Leverage Satellite Data to Help Validate Their Commitment on No Deforestation
Today, Upfield, a leading producer of plant-based products, announced partnership with Starling to ensure their ongoing support for Upfield’s vision for a “Better Plant Based Future” drives innovation in ingredient sourcing that protect the world’s precious ecosystems and preserves our planet for future generations.
In response to climate change and the devastating impact of deforestation, Upfield is committed to responsibly sourcing ingredients, paying particular attention to palm oil, soybean oil and paper, vetting partners to verify compliance with Upfield policies and maintaining transparency by publishing details of product ingredient sources. Upfield is committed to driving industry transformation and ensuring that deforestation doesn’t take place within their supply chain.
At the beginning of the year Upfield committed to source 100% of its palm oil from physically certified, sustainable sources by December 2019 and today can announce that they have achieved this target. All the palm oil Upfield directly purchases is now 100% physically certified to RPSO standards.
“This is an important step in delivering on our palm oil policy commitments,” said Sally Smith, Head of Sustainability, “ensuring we source our directly purchased ingredients sustainably and responsibly, particularly where there is a risk of deforestation, is a priority for Upfield. There continues to be more to do.”
Upfield sources both mass balance and segregated certified palm oil and will continue to work with suppliers and farmers to increase the proportion of segregated palm oil used in its products.
Upfield also shares the concerns about the production of soy products and is working toward full transparency, collaborating with community leaders and expert third parties. Ninety-five percent of Upfield’s soybean oil is grown in the United States and Canada and is compliant with local environmental regulations. The remaining five percent is sourced from Europe and Brazil, in compliance with the Amazon Basin Soy Moratorium Zone.
Additionally, today Upfield is announcing their partnership with Starling to use their innovative satellite monitoring technology platform to further support efforts in eradicating deforestation from their supply chain. Starling, created by Airbus and Earthworm, uses high resolution imagery and radar data to monitor land cover changes.
By mapping the location of mills within the supply chain, Upfield will be able to see where deforestation continues to occur. Upfield will be piloting the system initially in Indonesia where 50% of its palm oil and 70% of the high risks mills in their supply chain are located. In 2020 they will extend its use to cover their global palm oil supply chain. And finally, they will use the information to verify compliance and to help address deforestation risks with their suppliers.
Transparency is essential in ensuring sustainable supply chains and Upfield is committed to monitor, verify and act on the insights that Starling will provide. “Only by being equipped with information about deforestation and supply chains are companies able to take proactive action to tackle deforestation and evidence progress. That is what will eventually allow consumers and investors to really see which companies are truly walking the talk,” said Bastien Sachet, CEO of Earthworm Foundation.
At Upfield, we make people healthier and happier with great tasting, plant-based nutrition products that are better for the planet. As a global plant-based company, Upfield is the #1 producer of plant-based spreads with more than 60 brands, including iconic brands Flora, Rama, Blue Band, Proactive, Becel, I Can’t Believe It’s Not Butter and Country Crock. With headquarters in Amsterdam, we sell our products in over 95 countries and have 17 manufacturing sites throughout the world. The company employs over 3500 Associates. Since 1871, we have been the authority in the spreads category which gives us unmatched experience, know-how and inspiration. We are focused on leading in this new era focused on delivering healthier products that are great tasting and have superior quality and helps us deliver on our mission to create “Better Plant-based Future.” For more information, please visit our website at www.Upfield.com.
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Metanoia Announces Its Next Generation Broadband Access Technology14.10.2019 07:11:00 CEST | Press release
BROADBAND WORLD FORUM 2019--In order to respond to the ever increasing demand for higher data rate of xDSL over copper, coax lines, Metanoia Communications (“Metanoia”) announced today the launch of its latest family of chipsets that supports all the ITU-T Gfast (212MHz profile) and VDSL2 (35MHz profile) standards and builds on Metanoia’s proven Gfast, VDSL2 and ADSL2/2+ technology. With its MT-x2331 product family, Metanoia will deliver the industry first next generation broadband access xDSL PHY chipset for multiple applications including home gateways, low density xDSL Central Office systems and standalone xDSL termination, such as SFP modules. Emerging trends in the Broadband Access Networks make the use of standalone xDSL PHY solution more pertinent for WAN PHY agnostic platforms. A standalone xDSL PHY enables cost-effective upgrade of existing WAN deployments, an approach which is increasingly attractive to Operators. Metanoia MT-x2331 series is a chipset family that supports all
BIZCENTER USA Launches Coworking Facility in Orlando With Plans for Nationwide Franchise14.10.2019 04:01:00 CEST | Press release
Multimedia, Inc. (www.multimediausa.com) starts today the operations of BIZCENTER USA LLC, its affiliate for shared workspaces and virtual offices. Located on a fully owned 4,400 sq. ft. area in one of the most strategic regions of Orlando, Florida, BIZCENTER USA is offering brand-new state of the art executive suites in a facility with upscale conference rooms, reception, luxury lounge, and kitchen. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191013005018/en/ Founded in Orlando in 1991, Multimedia is a leading marketing and communications company, highly recognized worldwide for its professional integrity, serving advertising agencies, direct clients and media outlets across all continents. According to Fernando Mariano, president of both companies, the creation of BIZCENTER USA fulfills the needs for a stylish shared workspace and virtual office facility in Southwest Orlando. “Multimedia has strong ties with the Orlando
Vodafone Idea and Mavenir Partner to Extend Network as a Platform14.10.2019 01:00:00 CEST | Press release
Mavenir, the industry's only end-to-end cloud-native 4G and 5G network software provider for CSPs today announced the extension of its partnership with Vodafone Idea Limited (VIL), India’s leading telecom operator, to extend VIL Network as a Platform, reaching distributed presence across all the major Industrial, Commercial, and Services clusters in India. This partnership will focus on three thrust areas. First, building a universal secured Cloud capable of hosting multiple tenants and third-party applications. Second, building a fully automated platform that enables self-provisioning of various workloads. Third and most importantly, setting up a joint innovation lab and team that will consistently innovate on Chipset, Operating System, and work at Application level to offer unique APIs and enable new use cases and delightful experience to VIL customers. “Vodafone Idea has the largest Edge Cloud deployment in India. Our partnership with Mavenir will enable continued innovation in opti
SHINE Creates Therapeutics Division, Will Attend 2019 European Association of Nuclear Medicine Conference12.10.2019 04:00:00 CEST | Press release
SHINE Medical Technologies, LLC today announced the creation of a new division of the company — SHINE Therapeutics. The establishment of the division enhances the company’s ability to focus on filling critical future needs in the rapidly growing therapeutic isotope market, while continuing to leverage its radioisotope production expertise. The company’s Therapeutics division will initially focus on the development and commercialization of lutetium‑177, or Lu‑177, a therapeutic isotope that is combined with a disease-specific targeting molecule to treat cancer. Targeting molecules deliver Lu‑177 atoms to cancer sites throughout the body, where they directly irradiate cancer cells. The first Lu‑177-based targeted radiotherapy (for neuroendocrine tumors) reached the market in 2018. Many high-potential targeted molecules for the treatment of a range of other cancers with Lu-177 are currently under investigation. SHINE is also evaluating additional medical isotopes with therapeutic properti
Smart Taxation – A Step Towards a Fair, Efficient and Growth-Friendly European Taxation Approach11.10.2019 22:01:00 CEST | Press release
In a rapidly changing global economy, smart taxation is essential to drive growth and economic prosperity. However, the European Union (EU) continues to fall behind as it persists with a one-size-fits all taxation system. This year’s GLOBSEC Tatra Summit hosts a Focus Group, bringing together international experts, looking to reshape and support a smarter European tax policy. Europe is at a crossroads in adapting its tax policy to the realities of today’s global economy. The EU plays a key role in overseeing national tax rules in some areas - particularly in relation to EU business and consumer policies. The institutional changeover marks a perfect opportunity for the Tatra Summit to place major topics on the radar of decision-makers and offer efficient recommendations. So now is the time to adapt the EU’s taxation model to be fit-for-purpose. With member states around the table, European fiscal authorities should design a model that does not have a disruptive impact on national needs
Clovis Oncology Announces Rubraca®▼ (rucaparib) Now Available for Women with Relapsed Ovarian Cancer in England Through the Cancer Drugs Fund11.10.2019 13:19:00 CEST | Press release
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the National Institute for Health and Care Excellence (NICE) has recommended that women with relapsed ovarian cancer in England have access to rucaparib through the Cancer Drugs Fund (CDF).1 Rucaparib is available for use within the CDF as an option for the maintenance treatment of relapsed, platinum-sensitive high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer that has responded to platinum-based chemotherapy in adults, based on the conditions outlined in the managed access agreement. "Ovacome welcomes the availability of rucaparib via the CDF as an option for maintenance treatment of platinum-sensitive relapsed high grade serous epithelial ovarian cancer regardless of BRCA status or line of treatment in the relapsed maintenance setting,” said Victoria Clare, CEO of Ovacome, a United Kingdom ovarian cancer charity focused on providing support to anyone affected by ovarian cancer. “It is vital that the exp